IL1B and psoriasis: employed CRISPR-Cas9 technique to knock out Myd88 gene in epidermal keratinocytes, and indicated that Myd88 knockout could significantly reduce the expression of its downstream IL-1β and IL-36, which are two important factors regulating the inflammatory response of psoriasis (82).